Octreotide acetate (Wockhardt Limited)


Welcome to the PulseAid listing for the Octreotide acetate drug offered from Wockhardt Limited. This Somatostatin Analog [EPC],Somatostatin Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Wockhardt Limited
NON-PROPRIETARY NAME: Octreotide acetate
SUBSTANCE NAME: OCTREOTIDE ACETATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Somatostatin Analog [EPC],Somatostatin Receptor Agonists [MoA]
ROUTE: INTRAVENOUS; SUBCUTANEOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2011-05-11
END MARKETING DATE: 0000-00-00


Octreotide acetate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionOctreotide acetate from Wockhardt Limited
LABELER NAME: Wockhardt Limited
DEA SCHEDULE:
ACTIVE STRENGTH: 1000(ug/mL)
START MARKETING DATE: 2011-05-11
END MARKETING DATE: 0000-00-00
PRODUCT ID: 55648-632_3612a4d7-791d-4f11-aab1-4aefb5203bf1
PRODUCT NDC: 55648-632
APPLICATION NUMBER: ANDA090986

Other OCTREOTIDE ACETATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Fresenius Kabi USA, LLCOctreotide
Mylan Institutional LLCOctreotide Acetate
Novartis Pharmaceuticals CorporationSandostatin
Sagent PharmaceuticalsOctreotide Acetate
Sandoz IncOctreotide Acetate
Teva Parenteral Medicines, Inc.Octreotide Acetate
West-Ward Pharmaceuticals Corp.Octreotide Acetate
Wockhardt LimitedOctreotide acetate
Wockhardt USA LLC.Octreotide acetate